Major and minor salivary glands tumours

Critical Reviews in Oncology/Hematology

Volumn 45, Issue 2, 2003, Pages 215-225

  Licitra, Lisa ^a,g   Grandi, Cesare ^b   Prott, Franz Josef ^c,h   Schornagel, Jan H ^d   Bruzzi, Paulo ^e   Molinari, Roberto ^f,g  

^a EUROPEAN SCHOOL OF ONCOLOGY   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c ST JOSEFS HOSPITAL   (Germany)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY OF GENOA   (Italy)

^f IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h Institute of Radiotherapy Wiesbaden   (Germany)

Author keywords

Carcinomas; Salivary glands; Tumours

Indexed keywords

BENIGN TUMOR; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; DYSPHAGIA; EDEMA; ERYTHEMA; EXTERNAL OTITIS; FIBROSIS; HISTOLOGY; HUMAN; IRRADIATION; LYMPHOGRANULOMA VENEREUM; METASTASIS; MUCOSA INFLAMMATION; NEUTRON RADIATION; NUTRITION; OTITIS MEDIA; PALLIATIVE THERAPY; PAROTID GLAND; PAROTID GLAND CANCER; PROGNOSIS; REVIEW; RISK FACTOR; SALIVARY GLAND; SALIVARY GLAND TUMOR; SYMPTOM; TASTE DISORDER; TELANGIECTASIA; XEROSTOMIA;

HUMANS; NEOPLASM STAGING; PROGNOSIS; SALIVARY GLAND NEOPLASMS;

EID: 0037320077     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(02)00005-7     Document Type: Review

References (51)

1. Spitz M.R., Tilley B.C., Batsakis J.G., Gibeau J.M., Newell G.R. Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer. 54:1984;1854-1859.
2. Belsky J.L., Tachikawa K., Cihak R.W., Yamamoto T. Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970. JAMA. 219:1972;864-868.
3. Schneider A.B., Favus M.J., Stachura M.E., Arnold M.J., Frohman L.A. Salivary gland neoplasms as a late consequence of head and neck irradiation. Ann. Intern. Med. 87:1977;160-164.
4. Seifert G., Sobin L.H. The World Health Organization's Histological Classification of Salivary Gland Tumors. A commentary on the second edition. Cancer. 70:1992;379-385.
5. ICD-O (International Classification of Diseases for Oncology). In: Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, editors. 3rd ed. Geneva: World Health Organization, 2000.
6. Gal R. Fine needle aspiration of the salivary glands: a review. Op. Tech. Otolaryngol. Head Neck Surg. 7:1996;323-326.
7. UICC (International Union Against Cancer). TNM classification of malignant tumours. In: Sobin LH, Wittekind Ch, editors. 5th ed. New York: Wiley-Liss, 1997.
8. Spiro R.H., Huvos A.G. Stage means more than grade in adenoid cystic carcinoma. Am. J. Surg. 164:1992;623-628.
9. Frankenthaler R.A., Luna M.A., Lee S.S., Ang K.K., Byers R.M., Guillamondegui O.M., et al. Prognostic variables in parotid gland cancer. Arch. Otolaryngol. Head Neck Surg. 117:1991;1251-1256.
10. Fordice J., Kershaw C., El-Naggar A., Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch. Otolaryngol. Head. Neck. Surg. 125:1999;149-152.
11. Armstrong J.G., Harrison L.B., Thaler H.T., Friedlander-Klar H., Fass D.E., Zelefsky M.J., et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 69:1992;615-619.
12. Molinari R., Cantu G., Chiesa F., Grandi C. Retrospective comparison of conservative and radical neck dissection in laryngeal cancer. Ann. Otol. Rhinol. Laryngol. 89:1980;578-581.
13. Lingeman R.E., Helmus C., Stephens R., Ulm J. Neck dissection: radical or conservative. Ann. Otol. Rhinol. Laryngol. 86:1977;737-744.
14. Gavilan C., Gavilan J. Five-year results of functional neck dissection for cancer of the larynx. Arch. Otolaryngol. Head Neck Surg. 115:1989;1193-1196.
15. Borthne A., Kjellevold K., Kaalhus O., Vermund H. Salivary gland malignant neoplasms: treatment and prognosis. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;747-754.
16. Elkon D., Colman M., Hendrickson F.R. Radiation therapy in the treatment of malignant salivary gland tumors. Cancer. 41:1978;502-506.
17. Fitzpatrick P.J., Theriault C. Malignant salivary gland tumors. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1743-1747.
18. Harrison L.B., Armstrong J.G., Spiro R.H., Fass D.E., Strong E.W. Postoperative radiation therapy for major salivary gland malignancies. J. Surg. Oncol. 45:1990;52-55.
19. McNaney D., McNeese M.D., Guillamondegui O.M., Fletcher G.H., Oswald M.J. Postoperative irradiation in malignant epithelial tumors of the parotid. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;1289-1295.
20. North C.A., Lee D.J., Piantadosi S., Zahurak M., Johns M.E. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;1319-1326.
21. Griffin B.R., Laramore G.E., Russell K.J., Griffin T.W., Eenmaa J. Fast neutron radiotherapy for advanced malignant salivary gland tumors. Radiother. Oncol. 12:1988;105-111.
22. Griffin T.W., Pajak T.F., Laramore G.E., Duncan W., Richter M.P., Hendrickson F.R., et al. Neutron vs photon irradiation of inoperable salivary gland tumors: results of an RTOG-MRC Cooperative Randomized Study. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;1085-1090.
23. Stelzer K.J., Laramore G.E., Griffin T.W., Koh W.J., Austin-Seymour M., Russell K.J., et al. Fast neutron radiotherapy. The University of Washington experience. Acta Oncol. 33:1994;275-280.
24. Catterall M., Errington R.D. The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;1313-1318.
25. Douglas JG, Laramore GE, Austin-Seymour M, Koh WJ, Lindsley KL, Cho P, et al. Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands. Int J Radiat Oncol Biol Phys 1996;36:87-93.
26. Garden A.S., Weber R.S., Ang K.K., Morrison W.H., Matre J., Peters L.J. Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer. 73:1994;2563-2569.
27. Garden A.S., El-Naggar A.K., Morrison W.H., Callender D.L., Ang K.K., Peters L.J., et al. Postoperative radiotherapy for malignant tumors of the parotid gland. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;79-85.
28. Saroja K.R., Mansell J., Hendrickson F.R., Cohen L., Lennox A. An update on malignant salivary gland tumors treated with neutrons at Fermilab. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;1319-1325.
29. Krull A., Schwarz R., Heyer D., Timm H., Schmidt R. Results of neutron therapy in recurrent malignant salivary gland tumors in the head and neck area. Strahlenther. Onkol. 171:1995;265-271.
30. Sessions R.B., Lehane D.E., Smith R.J., Bryan R.N., Suen J.Y. Intra-arterial cisplatin treatment of adenoid cystic carcinoma. Arch. Otolaryngol. 108:1982;221-224.
31. Laramore G.E., Krall J.M., Griffin T.W., Duncan W., Richter M.P., Saroja K.R., et al. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;235-240.
32. Barnett T.A., Kapp D.S., Goffinet D.R. Adenoid cystic carcinoma of the salivary glands. Management of recurrent, advanced, or persistent disease with hyperthermia and radiation therapy. Cancer. 65:1990;2648-2656.
33. Gabriele P., Amichetti M., Orecchia R., Valdagni R. Hyperthermia and radiation therapy for inoperable or recurrent parotid carcinoma. A phase I/II study. Cancer. 75:1995;908-913.
34. Airoldi M., Brando V., Giordano C., Gabriele P., Bussi M., Cortesina G. Chemotherapy for recurrent salivary gland malignancies: experience of the ENT Department of Turin University. Orl; J. Oto-Rhino-Laryngol. and its Related Specialties. 56:1994;105-111.
35. Licitra L., Marchini S., Spinazze S., Rossi A., Rocca A., Grandi C., et al. Cisplatin in advanced salivary gland carcinoma. A phase II sudy of 25 patients. Cancer. 68:1991;1874-1877.
36. Licitra L., Cavina R., Grandi C., Palma S.D., Guzzo M., Demicheli R., et al. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann. Oncol. 7:1996;640-642.
37. Alberts D.S., Manning M.R., Coulthard S.W., Koopmann C.F.J., Herman T.S. Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer. 47:1981;645-648.
38. Belani C.P., Eisenberger M.A., Gray W.C. Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Med. Pediatr. Oncol. 16:1988;197-202.
39. Creagan E.T., Woods J.E., Rubin J., Schaid D.J. Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck. Cancer. 62:1988;2313-2319.
40. Dimery I.W., Legha S.S., Shirinian M., Hong W.K. Fluorouracil, doxorubicin, cyclophosphamide, and cysplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. J. Clin. Oncol. 8:1990;1056-1062.
41. Posner M.R., Ervin T.J., Weichselbaum R.R., Fabian R.L., Miller D. Chemotherapy of advanced salivary gland neoplasms. Cancer. 50:1982;2261-2264.
42. Jones A.S., Phillips D.E., Cook J.A., Helliwell T.R. A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands. Br. J. Cancer. 67:1993;112-114.
43. Schramm V.L.J., Srodes C., Myers E.N. Cisplatin therapy for adenoid cystic carcinoma. Arch. Otolaryngol. 107:1981;739-741.
44. Triozzi P.L., Brantley A., Fisher S., Cole T.B., Crocker I., Huang A.T. 5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer. 59:1987;887-890.
45. Venook A.P., Tseng A.J., Meyers F.J., Silverberg I., Boles R., Fu K.K., et al. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J. Clin. Oncol. 5:1987;951-955.
46. Shadaba A., Gaze M.N., Grant H.R. The response of adenoid cystic carcinoma to tamoxifen. J. Laryngol. Otol. 111:1997;1186-1189.
47. van der Hulst R.W., van Krieken J.H., van der Kwast T.H., Gerritsen J.J., Baatenburg D., Lycklama J.R., et al. Partial remission of parotid gland carcinoma after goserelin. Lancet. 344:1994;817.
48. Simpson J.R. Cancer of the salivary glands. Perez C.A., Brady L.W. Radiation Oncology. 1987;513-528 Lippincott, Philadelphia.
49. McNeese M.D., Fletcher G.H. Tumors of the major and minor salivary glands. Radiation Therapy of Head and Neck Cancer. 1989;181-196 Springer-Verlag, Berlin.
50. Moss WT. The salivary glands. In: Moss' Radiation Oncology: Rationale, Technique, Results. 7th ed. Mosby, 1994;121-131.
51. Johns M.E., Coulthard S.W. Survival and follow-up in malignant tumors of the salivary glands. Otolaryngol. Clin. North. Am. 10:1977;455-460.